Fortress Biotech, Inc.
FBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $17,631 | $16,413 | $13,139 | $15,120 |
| % Growth | 7.4% | 24.9% | -13.1% | – |
| Cost of Goods Sold | $5,755 | $4,939 | $4,790 | $5,805 |
| Gross Profit | $11,876 | $11,474 | $8,349 | $9,315 |
| % Margin | 67.4% | 69.9% | 63.5% | 61.6% |
| R&D Expenses | $208 | $8,126 | $3,938 | $9,940 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $17,415 | $38,757 | $25,663 | $26,720 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1,064 | $1,064 | $1,065 | $0 |
| Operating Expenses | $18,687 | $47,947 | $30,666 | $36,660 |
| Operating Income | -$6,811 | -$36,473 | -$22,317 | -$27,345 |
| % Margin | -38.6% | -222.2% | -169.9% | -180.9% |
| Other Income/Exp. Net | $15,664 | $24,819 | -$2,374 | $1,366 |
| Pre-Tax Income | $8,853 | -$11,654 | -$24,691 | -$25,979 |
| Tax Expense | $26 | $0 | $0 | $336 |
| Net Income | $5,850 | $15,486 | -$10,584 | -$6,765 |
| % Margin | 33.2% | 94.4% | -80.6% | -44.7% |
| EPS | 0.13 | 0.5 | -0.48 | -0.37 |
| % Growth | -74% | 204.2% | -29.7% | – |
| EPS Diluted | 0.11 | 0.45 | -0.48 | -0.37 |
| Weighted Avg Shares Out | 27,244 | 26,879 | 26,450 | 20,241 |
| Weighted Avg Shares Out Dil | 33,101 | 29,824 | 26,450 | 20,241 |
| Supplemental Information | – | – | – | – |
| Interest Income | $736 | $622 | $490 | $526 |
| Interest Expense | $2,415 | $2,518 | $2,805 | $2,594 |
| Depreciation & Amortization | $1,157 | $1,156 | $1,191 | $1,605 |
| EBITDA | $12,425 | -$8,424 | -$20,990 | -$21,780 |
| % Margin | 70.5% | -51.3% | -159.8% | -144% |